Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.

CEPHALALGIA is a prestigious peer-reviewed journal dedicated to the field of headache research and management, published by SAGE Publications Ltd. With a remarkable impact in the discipline, it holds the esteemed position of Q1 across both Medicine (miscellaneous) and Neurology (clinical) categories as of 2023, placing it in the top 10% of its field according to Scopus rankings. The journal has been actively contributing to the scientific community since 1981, offering a platform for groundbreaking studies, reviews, clinical guidelines, and original research articles that emphasize the complexities and multidimensional aspects of headache disorders. As a vital resource for clinicians, researchers, and students, CEPHALALGIA aims to enhance understanding and foster innovation in headache management, ultimately improving patient outcomes in this prevalent area of healthcare. Although it does not currently operate under an open access model, the journal's rigorous selection process ensures the publication of only the highest quality research, making it an essential reference for anyone serious about advancing knowledge in this critical domain.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

Journal of Headache and Pain, published by BMC, stands as a premier open-access platform dedicated to advancing research and practice in the fields of headache, pain medicine, and neurology. With its ISSN 1129-2369 and E-ISSN 1129-2377, this journal not only garners a significant global audience but also features a robust impact within the academic community, evidenced by its impressive rankings in 2023, placing it in the Q1 category for Anesthesiology and Pain Medicine, as well as Neurology (clinical), with Scopus ranks affirming its position among the top journals in its fields. Since its inception, the journal has provided a vital resource for researchers, professionals, and students, fostering collaboration and innovation through open access since 2011. The journal's scope encompasses interdisciplinary approaches to headache and pain management, offering insights that bridge clinical practice and research, thereby enhancing the understanding and treatment of these pervasive conditions. As it converges its efforts toward a continuous commitment to excellence through 2024 and beyond, the Journal of Headache and Pain remains an essential outlet for disseminating groundbreaking findings and facilitating knowledge exchange in a domain that profoundly impacts global health.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

Alzheimer's Research & Therapy is a leading peer-reviewed journal published by BMC, dedicated to advancing our understanding of Alzheimer's disease and other neurodegenerative disorders. As an Open Access journal since 2009, it ensures that vital research findings are freely accessible to the global community, facilitating collaboration and innovation in the field. The journal's commitment to quality is evident in its impressive impact factor and its prestigious ranking in the Q1 quartile across multiple categories including Cognitive Neuroscience and Neurology. With a Scopus rank placing it in the top tier of both Neuroscience and Neurology disciplines, Alzheimer's Research & Therapy serves as a crucial platform for researchers, clinicians, and students who seek to contribute to the fight against Alzheimer's and related disorders. The journal covers a wide range of topics and actively encourages submissions that explore therapeutic strategies and innovative research methodologies, enriching the scientific dialogue in this vital area of health.

BIPOLAR DISORDERS, published by Wiley, is a leading international journal dedicated to advancing the understanding and treatment of bipolar disorders. Since its establishment in 1999, the journal has become a vital resource in the fields of Biological Psychiatry and Psychiatry and Mental Health, currently ranked in the Q2 category for Biological Psychiatry and Q1 for Psychiatry and Mental Health as of 2023. With impressive Scopus rankings, it stands at 75th out of 567 in Psychiatry and Mental Health and 11th out of 51 in Biological Psychiatry, reflecting its influential role in shaping mental health research. The journal not only focuses on empirical studies, reviews, and clinical reports but also encourages innovative methodological advancements in understanding bipolar disorders. Although it does not offer Open Access, its extensive coverage from 1999 to 2024 ensures that practitioners, researchers, and students have access to a wealth of knowledge critical for the development of effective therapeutic interventions. For those engaging with cutting-edge research in psychiatric care, BIPOLAR DISORDERS serves as an essential platform for knowledge dissemination and academic discourse.

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.